FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308159487> ?p ?o ?g. }

• W4308159487 endingPage "121865" @default.
• W4308159487 startingPage "121865" @default.
• W4308159487 abstract "While lipid-lowering drugs have become a mainstay of clinical therapy these treatments only slow the progression of the disease and can have side effects. Thus, new treatment options are needed to supplement the effects of lipid lowering therapy for treating atherosclerosis. We examined the use of an inexpensive and widely available marine polysaccharide rhamnan sulfate as an oral therapeutic for limiting vascular inflammation and atherosclerosis.We found rhamnan sulfate enhanced the barrier function of endothelial cells, preventing the deposition of LDL and maintaining barrier function even in the presence of glycocalyx-degrading enzymes. Rhamnan sulfate was also found to bind directly to FGF-2, PDGF-BB and NF-κB subunits with high affinity. In addition, rhamnan sulfate was a potent inhibitor of NF-κB pathway activation in endothelial cells by TNF-α. We treated ApoE-/- mice with a high fat diet for 4 weeks and then an addition 9 weeks of high fat diet with or without rhamnan sulfate. Rhamnan sulfate reduced vascular inflammation and atherosclerosis in both sexes of ApoE-/- mice but had a stronger therapeutic effect in female mice. Oral consumption of rhamnan sulfate induced a significant decrease in cholesterol plasma levels in female mice but not in male mice. In addition, there was a marked reduction in inflammation for female mice in the liver and aortic root in comparison to male mice.Rhamnan sulfate has beneficial effects in reducing inflammation, binding growth factors and NF-κB, enhancing endothelial barrier function and reducing atherosclerotic plaque formation in ApoE-/- mice." @default.
• W4308159487 created "2022-11-08" @default.
• W4308159487 creator A5001564591 @default.
• W4308159487 creator A5003456246 @default.
• W4308159487 creator A5005099065 @default.
• W4308159487 creator A5005497488 @default.
• W4308159487 creator A5012970632 @default.
• W4308159487 creator A5023489815 @default.
• W4308159487 creator A5055461277 @default.
• W4308159487 creator A5056210370 @default.
• W4308159487 creator A5060124320 @default.
• W4308159487 creator A5069724772 @default.
• W4308159487 creator A5071715176 @default.
• W4308159487 creator A5073402861 @default.
• W4308159487 creator A5074009229 @default.
• W4308159487 creator A5077316454 @default.
• W4308159487 creator A5083084038 @default.
• W4308159487 creator A5086665145 @default.
• W4308159487 creator A5089949510 @default.
• W4308159487 date "2022-12-01" @default.
• W4308159487 modified "2023-10-18" @default.
• W4308159487 title "Rhamnan sulfate reduces atherosclerotic plaque formation and vascular inflammation" @default.
• W4308159487 cites W100734209 @default.
• W4308159487 cites W1059354827 @default.
• W4308159487 cites W1972230443 @default.
• W4308159487 cites W1978149131 @default.
• W4308159487 cites W1992547254 @default.
• W4308159487 cites W1998877093 @default.
• W4308159487 cites W1999946411 @default.
• W4308159487 cites W2007101511 @default.
• W4308159487 cites W2011333117 @default.
• W4308159487 cites W2021350406 @default.
• W4308159487 cites W2029340955 @default.
• W4308159487 cites W2032766057 @default.
• W4308159487 cites W2040735587 @default.
• W4308159487 cites W2050385895 @default.
• W4308159487 cites W2051352934 @default.
• W4308159487 cites W2052951555 @default.
• W4308159487 cites W2056371899 @default.
• W4308159487 cites W2060907991 @default.
• W4308159487 cites W2067116154 @default.
• W4308159487 cites W2067740038 @default.
• W4308159487 cites W2070244277 @default.
• W4308159487 cites W2084787851 @default.
• W4308159487 cites W2087829753 @default.
• W4308159487 cites W2091401980 @default.
• W4308159487 cites W2096501985 @default.
• W4308159487 cites W2097035877 @default.
• W4308159487 cites W2097749873 @default.
• W4308159487 cites W2101773230 @default.
• W4308159487 cites W2103439873 @default.
• W4308159487 cites W2104323764 @default.
• W4308159487 cites W2105534832 @default.
• W4308159487 cites W2107969192 @default.
• W4308159487 cites W2111766323 @default.
• W4308159487 cites W2113385672 @default.
• W4308159487 cites W2118335680 @default.
• W4308159487 cites W2121891676 @default.
• W4308159487 cites W2131939340 @default.
• W4308159487 cites W2133930237 @default.
• W4308159487 cites W2152543475 @default.
• W4308159487 cites W2152678130 @default.
• W4308159487 cites W2153870838 @default.
• W4308159487 cites W2156713309 @default.
• W4308159487 cites W2158214252 @default.
• W4308159487 cites W2160094856 @default.
• W4308159487 cites W2165130888 @default.
• W4308159487 cites W2166841168 @default.
• W4308159487 cites W2275204317 @default.
• W4308159487 cites W2344899129 @default.
• W4308159487 cites W2413821704 @default.
• W4308159487 cites W2560730412 @default.
• W4308159487 cites W2611625468 @default.
• W4308159487 cites W2767218826 @default.
• W4308159487 cites W2790325052 @default.
• W4308159487 cites W2884566343 @default.
• W4308159487 cites W2884986852 @default.
• W4308159487 cites W2889224376 @default.
• W4308159487 cites W2896130110 @default.
• W4308159487 cites W2898292656 @default.
• W4308159487 cites W2909765747 @default.
• W4308159487 cites W2917710461 @default.
• W4308159487 cites W2950997460 @default.
• W4308159487 cites W2956947939 @default.
• W4308159487 cites W3035817753 @default.
• W4308159487 cites W636946619 @default.
• W4308159487 doi "https://doi.org/10.1016/j.biomaterials.2022.121865" @default.
• W4308159487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36332287" @default.
• W4308159487 hasPublicationYear "2022" @default.
• W4308159487 type Work @default.
• W4308159487 citedByCount "3" @default.
• W4308159487 countsByYear W43081594872023 @default.
• W4308159487 crossrefType "journal-article" @default.
• W4308159487 hasAuthorship W4308159487A5001564591 @default.
• W4308159487 hasAuthorship W4308159487A5003456246 @default.
• W4308159487 hasAuthorship W4308159487A5005099065 @default.
• W4308159487 hasAuthorship W4308159487A5005497488 @default.
• W4308159487 hasAuthorship W4308159487A5012970632 @default.

• next